Avxentyev, N. A., Makarov, A. S., & Frolov, M. Y. Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer. IRBIS LLC.
Chicago Style (17th ed.) CitationAvxentyev, N. A., A. S. Makarov, and M. Yu Frolov. Direct Medical Costs of Using Enzalutamide or Abiraterone in Chemotherapy-naïve Patients with Metastatic Castration Resistant Prostate Cancer. IRBIS LLC.
MLA (9th ed.) CitationAvxentyev, N. A., et al. Direct Medical Costs of Using Enzalutamide or Abiraterone in Chemotherapy-naïve Patients with Metastatic Castration Resistant Prostate Cancer. IRBIS LLC.
Warning: These citations may not always be 100% accurate.